Medical Device Network on MSN
NAMSA acquires Labcorp’s medical device testing assets
The move adds Labcorp’s US biocompatibility, analytical testing, and preclinical research services to Namsa’s operations.
The company said that the sale of its medical device testing business would allow it to focus on core areas of preclinical drug development and chemical testing.
Namsa, which is backed by Archimed, has acquired Labcorp’s US-based early development medical testing business. No financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback